跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 178 条关于
“PI3Kγ”
全部
178
临床试验
94
药物
47
机构
0
资讯
37
去年
Combining PI3Kγ Inhibition with Radiotherapy Enhances Tumor Control in Pancreatic Cancer
16天前
Tumor-Associated Macrophages Emerge as Central Drivers of Gastric Cancer Peritoneal Metastasis and Immunotherapy Resistance
去年
Cancer Immunotherapy Strategies Repurposed for Autoimmune Disease Treatment Show Promise in Early Studies
11个月前
Therapeutic Cancer Vaccines Show Promise for Pancreatic Cancer Treatment Despite Immunosuppressive Challenges
去年
Lilly to Acquire Scorpion Therapeutics' Mutant-Selective PI3Kα Inhibitor Program for $2.5 Billion
去年
FDA Approves PI3Kα Inhibitor/Degrader Alpelisib for Advanced Breast Cancer
去年
Paxalisib, TTFields, and Proton Irradiation Show Promise in Neuro-oncology
去年
Aspirin Reduces Colorectal Cancer Recurrence in PI3K-Mutated Tumors
2年前
Relay Therapeutics' RLY-2608 Shows Promise in PI3Kα-Mutated Breast Cancer
去年
OnKure Therapeutics Advances Mutant-Specific PI3Kα Inhibitor OKI-219 Following Merger
第 1 页,共 4 页
上一页
下一页